AUG 11, 2026 · PHASE 2 TRIAL
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
ClinicalTrials.gov
This is a Phase 2 interventional trial registration with planned enrollment of 285 participants; no results are reported in this registry record, making it an early-stage, ongoing study.
Reported
Planned enrollment285
Study phasePhase 2
Primary outcome measurePercent Change From Baseline in Body Weight…